Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMS Acarbose vs Bayer Acarbose in Type 2 Diabetes
NCT01316861Phase 3Completed
- Sponsor
- EMS
- Start
- Sep 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acarbose in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by EMS. Primary endpoint: Glycosylated hemoglobin at Day 98. Started Sep 2012; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01316861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316861.